Click here to get full coverage on Precision Trading with GCTK Company (GCTK) Risk Zones - Stock Traders Daily

Precision Trading with GCTK Company (GCTK) Risk Zones  Stock Traders Daily

Precision Trading with GCTK Company (GCTK) Risk Zones - Stock Traders Daily

Click here to get full coverage on Diabetes tech firm lands $4M backing from single institutional investor - Stock Titan

Diabetes tech firm lands $4M backing from single institutional investor  Stock Titan

Diabetes tech firm lands $4M backing from single institutional investor - Stock Titan

Click here to get full coverage on AI Investing Insights - Official Homepage - Intellectia AI™ - Intellectia AI

AI Investing Insights - Official Homepage - Intellectia AI™  Intellectia AI

AI Investing Insights - Official Homepage - Intellectia AI™ - Intellectia AI

Click here to get full coverage on Entry Recap: Can GCTK disrupt its industry - Quarterly Portfolio Report & Consistent Income Trade Recommendations - baoquankhu1.vn

Entry Recap: Can GCTK disrupt its industry - Quarterly Portfolio Report & Consistent Income Trade Recommendations  baoquankhu1.vn

Entry Recap: Can GCTK disrupt its industry - Quarterly Portfolio Report & Consistent Income Trade Recommendations - baoquankhu1.vn

Click here to get full coverage on Glucotrack to effect a reverse stock split - Drug Delivery Business

Glucotrack to effect a reverse stock split  Drug Delivery Business

Glucotrack to effect a reverse stock split - Drug Delivery Business

Click here to get full coverage on Why Is Glucotrack Stock (GCTK) Up 150% Today? - TipRanks

Why Is Glucotrack Stock (GCTK) Up 150% Today?  TipRanks

Why Is Glucotrack Stock (GCTK) Up 150% Today? - TipRanks

Click here to get full coverage on Glucotrack (NASDAQ: GCTK) sets Oct 31 special meeting on Equity Purchase Agreement - Stock Titan

Glucotrack (NASDAQ: GCTK) sets Oct 31 special meeting on Equity Purchase Agreement  Stock Titan

Glucotrack (NASDAQ: GCTK) sets Oct 31 special meeting on Equity Purchase Agreement - Stock Titan

Click here to get full coverage on GlucoTrack stock tumbles after issuing $3.6M convertible note - Investing.com

GlucoTrack stock tumbles after issuing $3.6M convertible note  Investing.com

GlucoTrack stock tumbles after issuing $3.6M convertible note - Investing.com

Click here to get full coverage on Glucotrack, Inc. Announces USPTO Approval for CBGM Patents - TradingView

Glucotrack, Inc. Announces USPTO Approval for CBGM Patents  TradingView

Glucotrack, Inc. Announces USPTO Approval for CBGM Patents - TradingView

Click here to get full coverage on Glucotrack Stock Just Rose Over 123% Today: Here’s An Important Update - Stocktwits

Glucotrack Stock Just Rose Over 123% Today: Here’s An Important Update  Stocktwits

Glucotrack Stock Just Rose Over 123% Today: Here’s An Important Update - Stocktwits

Click here to get full coverage on Glucotrack to Participate in the Q3 Virtual Investor Summit - Yahoo Finance

Glucotrack to Participate in the Q3 Virtual Investor Summit  Yahoo Finance

Glucotrack to Participate in the Q3 Virtual Investor Summit - Yahoo Finance

Click here to get full coverage on GlucoTrack Shares Soar on Sixth Borough Capital Investment Surge​ - StocksToTrade

GlucoTrack Shares Soar on Sixth Borough Capital Investment Surge​  StocksToTrade

GlucoTrack Shares Soar on Sixth Borough Capital Investment Surge​ - StocksToTrade

Click here to get full coverage on GlucoTrack Appoints Dr. Hirsh as Medical Director - The Globe and Mail

GlucoTrack Appoints Dr. Hirsh as Medical Director  The Globe and Mail

GlucoTrack Appoints Dr. Hirsh as Medical Director - The Globe and Mail

Click here to get full coverage on Take Profit: Will GCTK outperform tech stocks - 2025 Bull vs Bear & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn

Take Profit: Will GCTK outperform tech stocks - 2025 Bull vs Bear & Free Expert Approved Momentum Trade Ideas  baoquankhu1.vn

Take Profit: Will GCTK outperform tech stocks - 2025 Bull vs Bear & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn

Click here to get full coverage on Implantable glucose sensor designed for 3 years, backed by new US patents - Stock Titan

Implantable glucose sensor designed for 3 years, backed by new US patents  Stock Titan

Implantable glucose sensor designed for 3 years, backed by new US patents - Stock Titan

Click here to get full coverage on Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology - The Globe and Mail

Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology  The Globe and Mail

Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology - The Globe and Mail

Click here to get full coverage on Revolutionary Diabetes Tech: Glucotrack's 3-Year Implantable Monitor Eliminates Daily Finger Pricks - Stock Titan

Revolutionary Diabetes Tech: Glucotrack's 3-Year Implantable Monitor Eliminates Daily Finger Pricks  Stock Titan

Revolutionary Diabetes Tech: Glucotrack's 3-Year Implantable Monitor Eliminates Daily Finger Pricks - Stock Titan

Click here to get full coverage on Revolutionary Implantable Diabetes Monitor Achieves 99% Data Capture Rate in Human Trial - Stock Titan

Revolutionary Implantable Diabetes Monitor Achieves 99% Data Capture Rate in Human Trial  Stock Titan

Revolutionary Implantable Diabetes Monitor Achieves 99% Data Capture Rate in Human Trial - Stock Titan

Click here to get full coverage on GCTK Stock Price, News & Analysis - Stock Titan

GCTK Stock Price, News & Analysis  Stock Titan

GCTK Stock Price, News & Analysis - Stock Titan

Click here to get full coverage on GlucoTrack’s Share Offering Spurs Market Activity​ - StocksToTrade

GlucoTrack’s Share Offering Spurs Market Activity​  StocksToTrade

GlucoTrack’s Share Offering Spurs Market Activity​ - StocksToTrade

Click here to get full coverage on GlucoTrack Strengthens IP for Implantable Glucose Monitoring Platform - TipRanks

GlucoTrack Strengthens IP for Implantable Glucose Monitoring Platform  TipRanks

GlucoTrack Strengthens IP for Implantable Glucose Monitoring Platform - TipRanks

Click here to get full coverage on GlucoTrack stock falls after announcing $4 million private placement By Investing.com - Investing.com South Africa

GlucoTrack stock falls after announcing $4 million private placement By Investing.com  Investing.com South Africa

GlucoTrack stock falls after announcing $4 million private placement By Investing.com - Investing.com South Africa

Click here to get full coverage on GCTK Stock Plummets to 52-Week Low of $0.09 Amid Market Turbulence - Investing.com

GCTK Stock Plummets to 52-Week Low of $0.09 Amid Market Turbulence  Investing.com

GCTK Stock Plummets to 52-Week Low of $0.09 Amid Market Turbulence - Investing.com

Click here to get full coverage on Revolutionary Blood Glucose Monitor Shows Promise: Direct Blood Measurement Could Transform Diabetes Care - Stock Titan

Revolutionary Blood Glucose Monitor Shows Promise: Direct Blood Measurement Could Transform Diabetes Care  Stock Titan

Revolutionary Blood Glucose Monitor Shows Promise: Direct Blood Measurement Could Transform Diabetes Care - Stock Titan

Click here to get full coverage on JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS - Stock Titan

JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS  Stock Titan

JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS - Stock Titan

Click here to get full coverage on GCTK - Glucotrack Latest Stock News & Market Updates - Stock Titan

GCTK - Glucotrack Latest Stock News & Market Updates  Stock Titan

GCTK - Glucotrack Latest Stock News & Market Updates - Stock Titan

Click here to get full coverage on Director and 10% Owner Drew Sycoff Acquires 182,540 Shares of GlucoTrack Inc (GCTK) - Yahoo Finance

Director and 10% Owner Drew Sycoff Acquires 182,540 Shares of GlucoTrack Inc (GCTK)  Yahoo Finance

Director and 10% Owner Drew Sycoff Acquires 182,540 Shares of GlucoTrack Inc (GCTK) - Yahoo Finance

Click here to get full coverage on Implantable, Hidden Continuous Glucose Monitoring Could Revolutionize Diabetes Care - The Globe and Mail

Implantable, Hidden Continuous Glucose Monitoring Could Revolutionize Diabetes Care  The Globe and Mail

Implantable, Hidden Continuous Glucose Monitoring Could Revolutionize Diabetes Care - The Globe and Mail

Click here to get full coverage on Glucotrack Appoints Peter C. Wulff as CFO - citybiz

Glucotrack Appoints Peter C. Wulff as CFO  citybiz

Glucotrack Appoints Peter C. Wulff as CFO - citybiz

Click here to get full coverage on GCTK Stock Price and Chart — NASDAQ:GCTK - TradingView

GCTK Stock Price and Chart — NASDAQ:GCTK  TradingView

GCTK Stock Price and Chart — NASDAQ:GCTK - TradingView

Click here to get full coverage on Why Is GlucoTrack (GCTK) Stock Down 36% Today? - InvestorPlace

Why Is GlucoTrack (GCTK) Stock Down 36% Today?  InvestorPlace

Why Is GlucoTrack (GCTK) Stock Down 36% Today? - InvestorPlace

Click here to get full coverage on GCTK stock touches 52-week low at $0.42 amid market fluctuations - Investing.com UK

GCTK stock touches 52-week low at $0.42 amid market fluctuations  Investing.com UK

GCTK stock touches 52-week low at $0.42 amid market fluctuations - Investing.com UK

Click here to get full coverage on GCTK stock plunges to 52-week low, touches $0.32 By Investing.com - Investing.com Australia

GCTK stock plunges to 52-week low, touches $0.32 By Investing.com  Investing.com Australia

GCTK stock plunges to 52-week low, touches $0.32 By Investing.com - Investing.com Australia

Click here to get full coverage on Glucotrack, Inc. (GCTK) stock: slides 30% despite trio of fresh USPTO patents for implantable CBGM platform - parameter.io

Glucotrack, Inc. (GCTK) stock: slides 30% despite trio of fresh USPTO patents for implantable CBGM platform  parameter.io

GCTK

Price Chart

Key Statistics

Technicals

About GCTK

Latest News

Precision Trading with GCTK Company (GCTK) Risk Zones - Stock Traders Daily

Diabetes tech firm lands $4M backing from single institutional investor - Stock Titan

AI Investing Insights - Official Homepage - Intellectia AI™ - Intellectia AI

Advanced Charts

Top Gainers

Top Losers